Newborn screening for sickle cell disease in Ivory Coast
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests a simple blood test at the clinic to screen newborns for sickle cell disease (SCD) and start early care. It aims to help babies get diagnosed and treated quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is 0 to 6 months old
- Your baby was born at 37 weeks or later (full-term)
- Your baby has not had a blood transfusion in the last 90 days
- You are willing to sign a consent form for your baby to join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a certain type of blood cell (megakaryocytes) in people with sickle cell disease. It aims to learn more about the disease and is only for patients followed at the Guadeloupe sickle cell center who are in a stable phase (no recent crisis or transfusion).
This study tests a new computer system to help hospitals quickly identify babies with sickle cell disease (an inherited blood disorder) right after birth or at early health visits. Finding sickle cell disease early helps prevent serious health problems and saves lives.
This study is testing a new way to screen all newborns for sickle cell disease in Mozambique. It aims to find babies with the condition early so they can get the right care from the start.
This trial tests a team-based care program for pregnant women with sickle cell disease. It aims to improve health for both mothers and babies through regular checkups and support.
This study tests a new way to screen babies for sickle cell disease at the point of care. It aims to make screening faster and easier for families and health workers.
This study screens healthy newborns for two inherited blood conditions: sickle cell disease and G6PD deficiency. It is meant to check if these conditions can occur together, which may help doctors provide better care.
Hear when a new Sickle Cell Disease (SCD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.